NCT06008444Completed
Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19
Chest Mobility, Cough Strength, Muscle Strength, Physical Activity and Quality of Life in Parkinson's Patients Who Have Had COVID-19
Source: ClinicalTrials.gov · Last updated 18 May 2025
Brief summary (registry, in English)
To comparative pain intensity, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients with post-COVID-19 and without post-COVID-19 was aimed in current study. Knowledge in the literature regarding this topic is still obscure.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 32 (actual)
- First submitted
- 21 Aug 2023
- Start date
- May 2023
- Primary completion date
- Aug 2024
- Lead sponsor
- Izmir Democracy University
- Diseases
- Parkinson disease
- NCT number
- NCT06008444
What you commit to
- Study type: Observational
- Participants enrolled: 32
- From May 2023 to the primary completion date, Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Sudden drug or dose change during the study period
Other illness
- A history of any acute/chronic orthopedic, cardiovascular, pulmonary, psychiatric or neuromuscular disease that may prevent measurements from being made.
- Having had myocardial infarction and pulmonary embolism in the last 30 days,
- Having a history of additional neurological (stroke, head trauma, peripheral nerve diseases, brain and spinal cord tumors, etc.) diseases other than Parkinson's disease
- Patients with blood pressure values above 140/90 and below 90/50 in blood pressure measurements made before the study, with arrhythmia on ECG, with a history of shortness of breath and/or palpitation
Other
- Having severe vision loss or vestibular dysfunction
Who the study is looking for
- Being diagnosed with COVID-19 at least 12 weeks ago and recovered,
- Being over 18 years old,
- Volunteering to participate in the research,
- Being diagnosed with Parkinson's disease
- Comorbid conditions (such as hypertension, diabetes) are under control
- Being able to perceive assessments (Standardized Mini Mental Test score of 24 and above)
- Having the ability to ambulate and walk independently
- Being in stage 1 - 4 according to the Modified Hoehn-Yahr Scale
- Not being diagnosed or suspected of COVID-19
- Being over 18 years old,
- Volunteering to participate in the research,
- Being diagnosed with Parkinson's disease
- Having comorbid conditions (such as hypertension, diabetes) which are under control
- Being able to perceive assessments (Standardized Mini Mental Test score of 24 and above)
- Having the ability to ambulate and walk independently
- Being in stage 1 - 4 according to the Modified Hoehn-Yahr Scale
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Izmir Democracy University Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.